| Year |
Citation |
Score |
| 2023 |
Kandzari DE, Garcia-Garcia HM, Stoler RC, Wang J, Picone M, Ben-Dor I, Garcia SA. Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 37493431 DOI: 10.1002/ccd.30783 |
0.308 |
|
| 2016 |
Waksman R, Goodroe R, Mishkel G, Tabrizchi A, Nazif T, Wang J, Lopez M, Scott T, Steinberg DH, Bastian R, Gai J, Torguson R. CRT-200.90 Percutaneous Coronary Intervention With Platinum Chromium Everolimus-eluting Stent Versus Coablt Chromium Everolimus Eluting Stent and Second Generation Paclitaxel-eluting Stents (REWARDS Premier TLX Trial) Jacc: Cardiovascular Interventions. 9: S30. DOI: 10.1016/J.JCIN.2015.12.122 |
0.321 |
|
| 2013 |
Brener SJ, Kereiakes DJ, Simonton CA, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Smith RS, Ying SW, Cutlip DE, Stone GW. Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial. American Heart Journal. 166: 1035-42. PMID 24268218 DOI: 10.1016/j.ahj.2013.08.030 |
0.521 |
|
| 2013 |
Forrest JK, Lansky AJ, Meller SM, Hou L, Sood P, Applegate RJ, Wang JC, Skelding KA, Shah A, Kereiakes DJ, Sudhir K, Cristea E, Yaqub M, Stone GW. Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years. The American Journal of Cardiology. 111: 1580-6. PMID 23499270 DOI: 10.1016/J.Amjcard.2013.01.330 |
0.329 |
|
| 2012 |
Pervaiz MH, Sood P, Sudhir K, Hermiller JB, Hou L, Hattori K, Su X, Cao S, Wang J, Applegate RJ, Kereiakes DJ, Yaqub M, Stone GW, Cutlip DE. Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions. Circulation. Cardiovascular Interventions. 5: 150-6. PMID 22438430 DOI: 10.1161/Circinterventions.111.965566 |
0.319 |
|
| 2011 |
Ito H, Hermiller JB, Yaqub M, Newman W, Sood P, Wang JC, Cannon L, Maddux JE, Sudhir K, Stone GW. Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trials. Journal of Interventional Cardiology. 24: 505-13. PMID 21919955 DOI: 10.1111/j.1540-8183.2011.00664.x |
0.511 |
|
| 2011 |
Hermiller JB, Yaqub M, Ito H, Sood P, Smith RS, Su X, Williams JE, Wang J, Caputo R, Applegate RJ, Sudhir K, Stone GW. Everolimus-eluting vs. paclitaxel-eluting coronary stents in the treatment of small vessels: pooled results of the SPIRIT III and SPIRIT IV randomized clinical trials through 2 years Cardiovascular Revascularization Medicine. 12: e7. DOI: 10.1016/J.CARREV.2011.04.263 |
0.331 |
|
| 2010 |
Kereiakes DJ, Cutlip DE, Applegate RJ, Wang J, Yaqub M, Sood P, Su X, Su G, Farhat N, Rizvi A, Simonton CA, Sudhir K, Stone GW. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). Journal of the American College of Cardiology. 56: 2084-9. PMID 21144968 DOI: 10.1016/j.jacc.2010.10.006 |
0.318 |
|
| 2010 |
Kereiakes DJ, Cannon LA, Feldman RL, Popma JJ, Magorien R, Whitbourn R, Dauber IM, Rabinowitz AC, Ball MW, Bertolet B, Kabour A, Foster MC, Wang JC, Underwood P, Dawkins KD. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial. Journal of the American College of Cardiology. 56: 264-71. PMID 20493653 DOI: 10.1016/j.jacc.2010.04.011 |
0.324 |
|
| 2010 |
Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. The New England Journal of Medicine. 362: 1663-74. PMID 20445180 DOI: 10.1056/NEJMoa0910496 |
0.517 |
|
| 2004 |
Kuntz RE, Wang JC, Mauri L, Cohen DJ. An evidence-based approach to the use of drug-eluting stents in clinical practice. The American Heart Hospital Journal. 2: 132-41. PMID 15805763 DOI: 10.1111/j.1541-9215.2004.02660.x |
0.305 |
|
| Show low-probability matches. |